This research team has expertise in Medicinal Chemistry (in association with Prana Biotechnology) and in biomarker discovery. More recently, it has focussed on the pathways leading to Parkinson’s disease, especially around the oxidative modifications of tau.
The Australian Imaging, Biomarker and Lifestyle (AIBL) Study, the Dementia Collaborative Research Centres (DCRC) and the Cooperative Research Centre for Mental Health (CRCMH) are intimately involved in our research programs, relying on patient cohorts for biomarker and imaging discovery in both neurodegenerative and psychotic illness.
Our research at a glimpse
- Extracellular vesicles in glioblastoma tissue
- Uncovering the role of exosome derived lipids in Alzheimer’s disease
- Discovering how toxic proteins traffic from cell to cell in Alzheimer’s disease
- Are exosomes driving Alzheimer’s disease pathogenesis?
- The role of tau protein in olfactory processes
- The role of peroxinitrite in depression
- The influence of alpha-synuclein on olfaction
- Effect of tau phosphorylation on exosome release in cell culture systems
- Effect of Abeta on excitotoxic signalling pathways
Brain health affects all Australians. You can support our research by making a donation or a bequest.